Enterprises responded to the COVID crisis by supporting remote working as a recovery requirement; in many cases, operational performance has been a mixed result. Pharmaceutical, Biotech and Healthcare organizations are increasingly reliant on seamless data integration to enable digital initiatives. From administration of clinical trials, to direct distribution channels and remote patient consultation/monitoring, the pandemic has accelerated delivery timelines on digital initiatives that were in-flight or being contemplated. Technologies such as artificial intelligence (AI), machine learning (ML) and the internet of things (IoT) are helping by connecting disparate data to yield better insights for improved decision making and planning while keeping patient information safe. Connecting this data requires a secure and interconnected, digital ecosystem. This session will discuss the key industry developments and areas of focus over the next 12 to 24 months as well as perspectives from the acclaimed panelists from industry leading organizations.